Seth Lerner, MD, FACS

Vadim Koshkin, MD

GU Oncology Now

<p>Seth Lerner, MD, FACS, Baylor College of Medicine, and Vadim Koshkin, MD, University of California, San Francisco, explain the implications of the latest data from the SWOG S1011 study on standard versus extended lymphadenectomy at time of radical cystectomy for metastatic urothelial carcinoma.<p><a href="https://guoncologynow.com/category/asco-2023" target="_blank" rel="noopener">View more ASCO 2023 videos</a>.</p></p>


Drs. Lerner, Koshkin on SWOG S1011 Results for Lymphadenectomy for Metastatic Urothelial Carcinoma

American Society of Clinical Oncology 2023 Annual Meeting

ASCO 2023

Drs. Lerner and Koshkin explain the implications of the latest data from the SWOG S1011 study for mUC.

Drs. Lerner, Koshkin on SWOG S1011 Results in Metastatic UC

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtables

The Uromigos

Uromigos Live 2024

AUC3

Localized

mHSPC/mCSPC

CRPC

Diagnostics

Prostate Cancer

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Renal Cell Carcinoma

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

Advancements in Oncology

The Oncology Brothers

Expert Interviews

Journal

Subscribe